{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:15:08Z","timestamp":1776320108379,"version":"3.50.1"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T00:00:00Z","timestamp":1397433600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094856","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T20:42:57Z","timestamp":1397508177000},"page":"e94856","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["The \u201cBrittle Response\u201d to Parkinson\u2019s Disease Medications: Characterization and Response to Deep Brain Stimulation"],"prefix":"10.1371","volume":"9","author":[{"given":"Daniel","family":"Martinez-Ramirez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Giugni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinata","family":"Vedam-Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna Wagle","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene A.","family":"Malaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaus R.","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon L.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly D.","family":"Foote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Okun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mds.25364","article-title":"Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson\u2019s disease","volume":"28","author":"C Warren Olanow","year":"2013","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/dia.2012.0058","article-title":"\u201cBrittleness\u201d in diabetes: easier spoken than broken","volume":"14","author":"C Voulgari","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/bmj.284.6321.1001","article-title":"Improved control of brittle Parkinsonism by separate administration of levodopa and benserazide","volume":"284","author":"DL McLellan","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.archger.2008.11.013","article-title":"Relationship between clinical phenotypes and cognitive impairment in Parkinson\u2019s disease (PD)","volume":"49","author":"JY Oh","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410270105","article-title":"Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson\u2019s disease","volume":"27","author":"MM Mouradian","year":"1990","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archneur.63.12.1756","article-title":"Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease","volume":"63","author":"RA Hauser","year":"2006","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson\u2019s disease","volume":"351","author":"S Fahn","year":"2004","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.22060","article-title":"Initiating levodopa\/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study","volume":"68","author":"F Stocchi","year":"2010","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"JE Ahlskog","year":"2001","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s004150050530","article-title":"Risk factors for levodopa-induced dyskinesias in Parkinson\u2019s disease","volume":"246","author":"F Grandas","year":"1999","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.63.2.205","article-title":"Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976\u20131990","volume":"63","author":"JA Van Gerpen","year":"2006","journal-title":"Arch Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/jpet.107.126219","article-title":"Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"323","author":"DB Putterman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JPD-2012-120103","article-title":"Levodopa-induced-dyskinesias clinical features, incidence, risk factors, management and impact on quality of life","volume":"2","author":"A Manson","year":"2012","journal-title":"J Parkinsons Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.870130605","article-title":"Young-onset Parkinson\u2019s disease revisited\u2013clinical features, natural history, and mortality","volume":"13","author":"A Schrag","year":"1998","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1353-8020(00)00005-5","article-title":"Levodopa in plasma correlates with body weight of parkinsonian patients","volume":"6","author":"T Muller","year":"2000","journal-title":"Parkinsonism Relat Disord"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3945\/ajcn.112.054916","article-title":"Sex and dieting modify the association between emotional eating and weight status","volume":"97","author":"S Peneau","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"ref17","first-page":"S122","article-title":"Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications","volume":"47","author":"TN Chase","year":"2000","journal-title":"Ann Neurol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/mds.870090403","article-title":"Utility of an objective dyskinesia rating scale for Parkinson\u2019s disease: inter- and intrarater reliability assessment","volume":"9","author":"CG Goetz","year":"1994","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1159\/000340071","article-title":"Weight change after globus pallidus internus or subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease and dystonia","volume":"90","author":"KA Mills","year":"2012","journal-title":"Stereotact Funct Neurosurg"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1227\/NEU.0b013e31820b52c5","article-title":"Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort","volume":"68","author":"MC Locke","year":"2011","journal-title":"Neurosurgery"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T20:16:44Z","timestamp":1597695404000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094856"}},"subtitle":[],"editor":[{"given":"Robert","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,14]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094856","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,14]]}}}